Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women
Clinical trial NCT03475706 · COMPLETED
Trial details
- NCT number
- NCT03475706
- Sponsor
- Velicept Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-01-24
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.